DeepMed Research

UNIVERSITY OF ILLINOIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1859-01-01

Employees: 10K

Market Cap: -

Website: http://www.illinois.edu

Clinical Trials

A Pilot Observational Clinical Survey: Impacts of Tahitian Noni Juice on the Quality of Life of Patients With Osteoarthritis

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Dietary Supplement: Noni Juice

First Posted Date: 2010-02-17

Last Posted Date: 2010-02-17

Lead Sponsor: University of Illinois at Chicago

Registration Number: NCT01070264

Locations: 🇺🇸
University of Illinois-Chicago College of Medicine at Rockford, Rockford, Illinois, United States

Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity

Not Applicable

Completed

Conditions: Ulcerative Colitis

Interventions: Other: dietary intervention with no-carrageenan diet
Dietary Supplement: carrageenan

First Posted Date: 2010-02-09

Last Posted Date: 2019-11-26

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 15

Registration Number: NCT01065571

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Behavioral: Aerobic training
Behavioral: Resistance training

First Posted Date: 2010-01-28

Last Posted Date: 2013-12-18

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 354

Registration Number: NCT01058213

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Nurse Managed Upper Body Strength Training in Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Behavioral: Exercise-specific self-efficacy
Behavioral: Gentle chair exercise
Behavioral: upper body strength training

First Posted Date: 2010-01-27

Last Posted Date: 2010-01-27

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 208

Registration Number: NCT01057797

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Randomized Controlled Trial of Wellness Recovery Action Planning

Not Applicable

Completed

Conditions: Mental Disorders

Interventions: Behavioral: Wellness Recovery Action Planning (WRAP)

First Posted Date: 2009-12-03

Last Posted Date: 2020-01-10

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 555

Registration Number: NCT01024569

Locations: 🇺🇸
University of Illinois at Chicago, Department of Psychiatry, Chicago, Illinois, United States

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Phase 1

Withdrawn

Conditions: Angioid Streaks

Interventions: Drug: ranibizumab

First Posted Date: 2009-11-18

Last Posted Date: 2012-07-02

Lead Sponsor: University of Illinois at Chicago

Registration Number: NCT01015495

Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment

Not Applicable

Withdrawn

Conditions: Posttraumatic Stress Disorders
Pain
Traumatic Brain Injury
Trauma
Combat Disorders

Interventions: Device: TMRDU

First Posted Date: 2009-11-03

Last Posted Date: 2019-07-26

Lead Sponsor: University of Illinois at Chicago

Registration Number: NCT01007006

Locations: 🇺🇸
James A Haley VA Hospital and Polytrauma Facility, Tampa, Florida, United States
🇺🇸
Naval Hospital Camp Pendleton, Camp Pendleton, California, United States
🇺🇸
Ireland Army Community Hospital, Fort Knox, Kentucky, United States

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care

Phase 4

Completed

Conditions: Heart Failure

Interventions: Other: Digoxin Dosing per Nomogram
Drug: Digoxin

First Posted Date: 2009-11-01

Last Posted Date: 2014-05-22

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 131

Registration Number: NCT01005602

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Research Investigation of Soy and Estrogen

Phase 2

Completed

Conditions: Menopause
Hot Flashes

Interventions: Dietary Supplement: Soy Phytoestrogen
Drug: Estradiol
Drug: MPA Placebo
Drug: Medroxyprogesterone Acetate (MPA)
Drug: Soy Placebo

First Posted Date: 2009-10-19

Last Posted Date: 2020-12-07

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 96

Registration Number: NCT00997893

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies

Not Applicable

Completed

Conditions: Acute Leukemia
Lymphoblastic Leukemia
Chronic Myeloid Leukemia
Acute Myeloid Leukemia
Non Hodgkins Lymphoma

Interventions: Radiation: IM-TMI (6Gy)
Radiation: IM-TMI (3Gy)
Radiation: IM-TMI (9Gy)
Radiation: IM-TMI (12Gy)

First Posted Date: 2009-10-01

Last Posted Date: 2021-06-14

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 14

Registration Number: NCT00988013

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy